The Effects of Keeping the Patient in a Sitting Position for One Minute After Spinal Anesthesia

February 6, 2019 updated by: Gulsah Karaoren, Umraniye Education and Research Hospital

The Effects of Keeping the Patient in a Sitting Position for One Minute After Spinal Anesthesia on Hypotension, Nausea-vomiting and Ephedrine Consumption

The aim of this study was to examine the effect of keeping the patient in a sitting position for 1 minute after spinal anaesthesia in elective caesarean operations, primarily on the formation of hypotension and secondarily on nausea-vomiting, the need for ephedrine and the block characteristics.

Study Overview

Study Type

Interventional

Enrollment (Actual)

214

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • aged 18 - 45 years,
  • ASA physical status
  • I - II,
  • BMI of 25-30
  • who were undergoing elective CS

Exclusion Criteria:

  • vertebral anomaly,
  • peripheral vascular disease,
  • cardiovascular or psychiatric disorder,
  • severe anemia,
  • coagulopathy
  • infection in the intervention region

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group 1
12.5 mg 0.5% hyperbaric bupivacaine
keeping the patient in a sitting position after spinal anaesthesia
Active Comparator: Group 2
10 mg 0.5% hyperbaric bupivacaine
keeping the patient in supine position after spinal anaesthesia
Active Comparator: Group 3
12.5 mg 0.5% hyperbaric bupivacaine
keeping the patient in supine position after spinal anaesthesia

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
systolic arterial hypotension
Time Frame: every 3 minutes until the delivery and every 5 minutes until the end of surgery
reduction of >25% in the basal systolic arterial pressure
every 3 minutes until the delivery and every 5 minutes until the end of surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
sensory block
Time Frame: 10 minutes after spinal block
assesment of the time to reach T12 level with pin prick test
10 minutes after spinal block
ephedrine requirement time
Time Frame: 1 hour after spinal block
the time to first administration of ephedrine as minutes after spinal block
1 hour after spinal block
amount of ephedrine
Time Frame: 1 hour after spinal block
administrated total ephedrine dosage as mg during surgery
1 hour after spinal block
surgeon and patient satisfaction
Time Frame: 24 hours after spinal block
1= poor, 2=fair, 3= good, 4= very good
24 hours after spinal block
motor block
Time Frame: 24 hours after spinal block
time to Bromage Score 0 after applying spinal block
24 hours after spinal block

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2017

Primary Completion (Actual)

November 1, 2017

Study Completion (Actual)

December 1, 2017

Study Registration Dates

First Submitted

February 5, 2019

First Submitted That Met QC Criteria

February 6, 2019

First Posted (Actual)

February 7, 2019

Study Record Updates

Last Update Posted (Actual)

February 7, 2019

Last Update Submitted That Met QC Criteria

February 6, 2019

Last Verified

February 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • GK12

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypotension

Clinical Trials on sitting position

3
Subscribe